2026 will likely be the year the U.S. economy becomes a two-speed machine, where: And in the middle: confusion, political noise, and a Federal Reserve… Read More »5 Major Economic Predictions For 2026

It is well established by empirical research that company insiders realize significant abnormal profits by trading their own company’s stock. Sattar Mansi, Lin Peng, Jianping… Read More »When You Buy The Hype, Insiders Love To Sell

Driven by rapid innovation and growing investor interest, the space economy is gaining momentum. Rising interest in space tourism, the expanding role of space-based technologies… Read More »Invest In Tomorrow’s Space Economy With These ETFs

Freeport-McMoRan (NYSE:FCX) shares rose 3% Monday to close at $50.64 per share, putting them just 8% below the May 2024 high of $54.86 and about 16%… Read More »Copper Hits $12,000 A Ton. Time To Mine Freeport-McMoRan For More Profits?

Truth Social parent Trump Media & Technology Group (DJT) shocked the market Thursday with the announcement it was entering into an all-stock merger with TAE Technologies, a leading… Read More »So, Trump Media Is An Energy Stock Now? That Doesn’t Mean You Should Buy

An easing in inflation pressures helped stabilize markets in Thursday’s trading session, although a few notable stocks had already printed fresh highs ahead of November’s… Read More »3 Stocks To Watch Near All-Time Highs

There are plenty of reasons to own international stocks in a portfolio. Some investors want foreign stocks in their portfolios to round out their exposure… Read More »The Best International-Stock Funds And ETFs To Buy

Building wealth through dividends requires more than chasing high yields. The path to “getting rich” combines meaningful current income with consistent dividend growth, backed by… Read More »5 Dividend Powerhouses That Could Transform Your Portfolio Into A Wealth-Building Machine

The Federal Reserve announced its third interest rate cut of 25 basis points Wednesday amid persistent inflation and a softening job market. This lowered the… Read More »Fed Cuts Rates, Signals Caution Ahead: 5 Bank Stocks Set To Benefit

Swiss oncology powerhouse, BeOne Medicines, has emerged as one of 2025’s top performers in a sector often plagued by volatility. Year-to-date, shares have rocketed 75%, outpacing many… Read More »Up 75%, This Biotech Could Soar Even Higher In 2026